Skip to main content
| News

Eight startups from Basel Area feature in TOP 100 Swiss Startups

08.09.2022

Among the most promising startups in Switzerland eight companies from Basel Area's startup ecosystem have been named. They are some of the winners of Venturelab’s TOP 100 Swiss Startups 2022. Five biotech startups have been or are being supported by BaseLaunch.

The startup space in Schlieren was the venue for the announcement of the most promising startups in Switzerland (img: Venturelab)

The jury of the TOP 100 Swiss Startup Awards 2022 has honored the best startups in Switzerland. Eight companies from the cantons of Basel-Stadt and Basel-Landschaft did well. This was the twelfth year of the competition organized by Venturelab. It was supported by Credit Suisse and the Swiss Venture Club.

Five of the awarded firms from the two Basel cantons have been or are being supported by the biotech accelerator and incubator BaseLaunch. This includes Tolremo Therapeutics from Muttenz in 14th place, which has developed an active substance search engine to identify innovative drug resistance regulators and facilitates low-molecular weight therapies to combat these. Anaveon with headquarters at Tech Park Basel came in 30th place. It transforms potent cytokines into life-saving treatments.

Alentis Therapeutics also features in BaseLaunch’s portfolio. Located on the main campus of the Switzerland Innovation Park Basel Area in Allschwil, it took 51st place. The biotechnology company develops treatments for fibrosis. NextImmune from Basel, an innovative immunotherapy provider, came in 72nd place. Synendos Therapeutics from Basel took 79th place. It researches endocannabinoid modulators to restore the brain’s natural functions for those with central nervous system disorders.

Resistell is the top-ranked medtech startup

Furthermore, the jury placed Resistell at number 12. The medtech startup from Muttenz uses its nanomotion technology platform to rapidly find the correct antibiotic for each case, thus combating the issue of resistance. Resistell is not only the top-ranked startup from the Basel Area, but also the top-ranked startup in the medtech category overall. Bright Peak Therapeutics, a biotech startup from Basel, develops innovative cytokine active substances and took 33rd place. Qnami from Muttenz was assigned to 39th place. The startup uses quantum mechanics to measure things that have not been quantifiable to date on an atomic level.

Additionally, Tinamu Labs came in 32nd place. The spin-off from the Swiss Federal Institute of Technology Zurich won with its drone technology the i4Challenge 2020 run by the investment and innovation promotion agency Basel Area Business & Innovation.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

KUORI developing biodegradable plastics
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Cell and gene therapies gain momentum in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
BLKB expanding support for startups
Basel Area Business & Innovation, Innovation, Invest

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Read More
Combatting the rise of antimicrobial resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...

Read More
AMR Action Fund invests in new antibiotics developed by BioVersys
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Read More
Investors give Resistell 8.5 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...

Read More
1 2 3 31

Do you have a question? We'd like to hear from you.